References: Noninvasive assessment of liver fibrosis

  • Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodriguez-Peralvarez M, et al. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess 2015;19(9):1–409, v-vi. https://www.ncbi.nlm.nih.gov/pubmed/25633908
  • de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63(3):743–52. https://www.ncbi.nlm.nih.gov/pubmed/26047908
  • de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022;76(4):959-74. https://www.ncbi.nlm.nih.gov/pubmed/3512073
  • European Association for the Study of the Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63(1):237–64. https://www.ncbi.nlm.nih.gov/pubmed/25911335
  • European Association for the Study of the Liver Clinical Practice Guideline Panel. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75(3):659-89. https://www.ncbi.nlm.nih.gov/pubmed/34166721
  • Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol 2018;44(12):2419–40. https://www.ncbi.nlm.nih.gov/pubmed/30209008
  • Majumdar A, Campos S, Gurusamy K, Pinzani M, Tsochatzis EA. Defining the minimum acceptable diagnostic accuracy of noninvasive fibrosis testing in cirrhosis: a decision analytic modeling study. Hepatology 2020;71(2):627–42. https://www.ncbi.nlm.nih.gov/pubmed/31297832
  • Majumdar A, Pinzani M. Non-invasive assessment of fibrosis and cirrhosis. In: Sherlock’s diseases of the liver and biliary system. 13th Hoboken, NJ: John Wiley & Sons Ltd.; 2018.
  • Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, et al. Guidelines on the management of abnormal liver blood tests. Gut 2018;67(1):6–19. https://www.ncbi.nlm.nih.gov/pubmed/29122851
  • Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, et al. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Am J Gastroenterol 2021;116(4):723-32. https://www.ncbi.nlm.nih.gov/pubmed/33982942
  • Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology 2017;152(6):1544–77. https://www.ncbi.nlm.nih.gov/pubmed/28442120